These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32324704)

  • 1. Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes.
    Brichetto G; Zaratin P
    Curr Opin Neurol; 2020 Jun; 33(3):295-299. PubMed ID: 32324704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.
    Terwee CB; Elders PJM; Blom MT; Beulens JW; Rolandsson O; Rogge AA; Rose M; Harman N; Williamson PR; Pouwer F; Mokkink LB; Rutters F
    Diabetologia; 2023 Aug; 66(8):1357-1377. PubMed ID: 37222772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common patient-reported outcomes across ICHOM Standard Sets: the potential contribution of PROMIS®.
    Terwee CB; Zuidgeest M; Vonkeman HE; Cella D; Haverman L; Roorda LD
    BMC Med Inform Decis Mak; 2021 Sep; 21(1):259. PubMed ID: 34488730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in multiple sclerosis: a systematic comparison of available measures.
    Khurana V; Sharma H; Afroz N; Callan A; Medin J
    Eur J Neurol; 2017 Sep; 24(9):1099-1107. PubMed ID: 28695634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring Fatigue in Multiple Sclerosis: There may be Trouble Ahead.
    Close J; Vandercappellen J; King M; Hobart J
    Neurol Ther; 2023 Oct; 12(5):1649-1668. PubMed ID: 37353721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions.
    Zaratin P; Vermersch P; Amato MP; Brichetto G; Coetzee T; Cutter G; Edan G; Giovannoni G; Gray E; Hartung HP; Hobart J; Helme A; Hyde R; Khan U; Leocani L; Mantovani LG; McBurney R; Montalban X; Penner IK; Uitdehaag BMJ; Valentine P; Weiland H; Bertorello D; Battaglia MA; Baneke P; Comi G;
    Mult Scler Relat Disord; 2022 May; 61():103757. PubMed ID: 35367873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting.
    Lanzillo R; Sparaco M; Lavorgna L; Carmisciano L; Signoriello E; Signori A; Costabile T; Maniscalco GT; Saccà F; Cepparulo S; Russo CV; Bisecco A; Frattaruolo N; Strianese A; Lus G; Brescia Morra V; Bonavita S
    Neurol Sci; 2020 Nov; 41(11):3235-3241. PubMed ID: 32388646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study.
    Jakimovski D; Kavak KS; Zakalik K; McGraw C; Gottesman M; Coyle PK; Zivadinov R; Weinstock-Guttman B;
    J Neurol Sci; 2023 Dec; 455():122781. PubMed ID: 37979415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.
    Nowinski CJ; Miller DM; Cella D
    Neurotherapeutics; 2017 Oct; 14(4):934-944. PubMed ID: 28913785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Patient-reported outcomes in multiple sclerosis care.
    D'Amico E; Haase R; Ziemssen T
    Mult Scler Relat Disord; 2019 Aug; 33():61-66. PubMed ID: 31154262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial.
    Chu NY; Watson KE; Al Hamarneh YN; Yushko L; Tsuyuki RT; Smyth P
    BMC Neurol; 2023 Feb; 23(1):53. PubMed ID: 36732694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care - updates at the 2023 plenary event.
    Zaratin P; Samadzadeh S; Seferoğlu M; Ricigliano V; Dos Santos Silva J; Tunc A; Brichetto G; Coetzee T; Helme A; Khan U; McBurney R; Peryer G; Weiland H; Baneke P; Battaglia MA; Block V; Capezzuto L; Carment L; Cortesi PA; Cutter G; Leocani L; Hartung HP; Hillert J; Hobart J; Immonen K; Kamudoni P; Middleton R; Moghames P; Montalban X; Peeters L; Sormani MP; van Tonder S; White A; Comi G; Vermersch P
    Front Neurol; 2024; 15():1407257. PubMed ID: 38974689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a standard set of PROs and generic PROMs for Dutch medical specialist care : Recommendations from the Outcome-Based Healthcare Program Working Group Generic PROMs.
    Oude Voshaar M; Terwee CB; Haverman L; van der Kolk B; Harkes M; van Woerden CS; van Breda F; Breukink S; de Hoop I; Vermeulen H; de Graaf E; Hazelzet J; van Leiden B; Stienen J; Hoekstra M; Bart H; van Bommel H; Determann D; Verburg M; van der Wees P; Beurskens AJ
    Qual Life Res; 2023 Jun; 32(6):1595-1605. PubMed ID: 36757571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.
    ; Rieckmann P; Centonze D; Elovaara I; Giovannoni G; Havrdová E; Kesselring J; Kobelt G; Langdon D; Morrow SA; Oreja-Guevara C; Schippling S; Thalheim C; Thompson H; Vermersch P; Aston K; Bauer B; Demory C; Giambastiani MP; Hlavacova J; Nouvet-Gire J; Pepper G; Pontaga M; Rogan E; Rogalski C; van Galen P; Ben-Amor AF
    Mult Scler Relat Disord; 2018 Jan; 19():153-160. PubMed ID: 29241142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis.
    Greene N; Quéré S; Bury DP; Mazerolle F; M'Hari M; Loubert A; Regnault A; Higuchi K
    J Patient Rep Outcomes; 2023 Jul; 7(1):61. PubMed ID: 37402086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining a Research Agenda for Patient-Reported Outcomes in Surgery: Using a Delphi Survey of Stakeholders.
    Pezold ML; Pusic AL; Cohen WA; Hollenberg JP; Butt Z; Flum DR; Temple LK
    JAMA Surg; 2016 Oct; 151(10):930-936. PubMed ID: 27437666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
    Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Mowry EM; Marrie RA
    Mult Scler Relat Disord; 2019 Apr; 29():86-93. PubMed ID: 30690340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which patient reported outcomes (PROs) and patient reported outcome measures (PROMs) do researchers select in stress urinary incontinence surgical trials? - a systematic review.
    Loganathan J; Coffey J; Doumouchtsis SK;
    Int Urogynecol J; 2022 Nov; 33(11):2941-2949. PubMed ID: 35254471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Multiple Sclerosis Indicators for Value-Based Contracting Using the Delphi Method.
    Swart ECS; Neilson LM; Good CB; Shrank WH; Henderson R; Manolis C; Parekh N
    J Manag Care Spec Pharm; 2019 Jul; 25(7):753-760. PubMed ID: 31232201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.